Analyst Ratings January 28, 2026

Goldman Sachs Lifts Golar LNG Price Target to $56, Cites Gimi Production Strength

Analysts point to higher Gimi output and refined contract modeling as drivers behind the modest target bump and maintained Buy rating

By Caleb Monroe GLNG
Goldman Sachs Lifts Golar LNG Price Target to $56, Cites Gimi Production Strength
GLNG

Goldman Sachs increased its price target on Golar LNG Ltd. to $56 from $55 while keeping a Buy rating ahead of the company’s fourth-quarter 2025 results. The new target implies roughly 40% upside from recent levels and follows modest adjustments to the bank’s EBITDA forecasts driven by stronger expected production from the Gimi vessel and weaker commodity-linked revenues from Hilli.

Key Points

  • Goldman Sachs raised its Golar LNG price target to $56 from $55 and retained a Buy rating; the new target implies nearly 40% upside from a $40.22 share price.
  • The bank lifted its Q4 2025 EBITDA estimate to $87 million versus a consensus of $85 million, citing higher production from the Gimi vessel that partially offsets lower commodity-driven revenues from Hilli.
  • Goldman projects 2026 EBITDA will fall to $252 million as Gimi’s full-year contribution is offset by Hilli’s planned July 2026 relocation; valuation metrics show a high P/E of 72.94 but a low PEG of 0.2.

Goldman Sachs has raised its price objective on Golar LNG Ltd. to $56.00 from $55.00 and left its rating at Buy as the company approaches its fourth-quarter 2025 earnings release. The revised target sits just under the Street’s top projection of $57.00 and implies nearly 40% upside from a recent share price of $40.22.

Analysts continue to show strong conviction in the name, with the stock carrying a consensus Buy rating and a numeric consensus score of 1.38. Market valuation metrics cited alongside the brokerage’s view show a mixed picture: the company trades at a high EBITDA multiple, yet a low PEG ratio of 0.2 suggests potential undervaluation relative to expected growth.

Goldman Sachs adjusted its short-term EBITDA estimate for Golar, projecting fourth-quarter 2025 EBITDA of $87 million. That is marginally above consensus of $85 million and slightly higher than the firm’s prior $83 million projection. The bank attributes the uptick to increased production from the Gimi vessel, which it expects will partly offset lower commodity-driven revenues associated with the Hilli vessel during the quarter.

For additional context on recent performance, Golar’s trailing twelve-month EBITDA is reported at $134.19 million. Revenue growth for fiscal 2025 is forecast at 47%.

Looking further out, Goldman Sachs forecasts that Golar’s full-year EBITDA for 2026 will decline year-over-year to $252 million. The firm’s view is that while Gimi contributes for the full year, that benefit will be counterbalanced by the planned relocation of Hilli in July 2026 ahead of its 2027 Argentina contract, producing a net reduction in annual EBITDA.

The investment bank expects the company’s forthcoming earnings call to address several strategic and operational topics, including potential plans for a fourth vessel, efforts to monetize the commodity option value embedded in Argentina contracts, ongoing capital return programs, and the board’s review of strategic alternatives. Goldman Sachs describes its own modest increase to estimates and the price target as the result of refining its model of Golar’s executed contract portfolio.

Valuation measures cited by the bank show the stock trading at a P/E ratio of 72.94, while the PEG ratio stands at 0.2. Goldman notes that the shares trade at a premium to current earnings on a price-to-earnings basis, yet may look attractive when judged against expected growth rates reflected in the PEG metric.

Recent company reporting for the third quarter of 2025 showed operating revenue of $123 million, narrowly missing a forecast of $124.67 million. Adjusted EBITDA for the quarter was reported at approximately $83 million, about 2% below a consensus estimate of $85 million. Management pointed to the ongoing production ramp of the Gimi vessel and weaker-than-anticipated commodity-linked revenues from the Hilli contract as contributors to the shortfall.

Despite the near-term misses, other analysts have maintained positive stances on the stock. One firm reiterated a Buy rating with a $50 price target, and the stock rose in response to the most recent earnings call, reflecting investor receptivity to management commentary and the company’s near-term outlook.

Investors and market participants will likely focus on the upcoming quarter’s operational updates and the company’s commentary on vessel deployment and contract monetization strategies. Those elements, combined with the bank’s refined contract modeling, underpin Goldman Sachs’ decision to nudge its estimates and lift the price target while preserving a constructive rating.


What to watch

  • Execution of the Gimi production ramp and near-term output levels.
  • Commodity-linked revenue performance from the Hilli vessel and any impacts from its planned relocation.
  • Management commentary on vessel additions, contract option monetization, capital returns, and strategic alternatives.

Risks

  • Operational ramp risk: Continued production ramp of the Gimi vessel could keep near-term results below expectations, affecting EBITDA and revenues - impacts energy and shipping sectors.
  • Commodity revenue variability: Lower-than-expected commodity-linked revenues from the Hilli contract may depress results and valuations - impacts energy and commodity-linked revenue streams.
  • Contract timing and relocation: The planned relocation of Hilli in July 2026 could reduce full-year EBITDA in 2026 and introduce timing risk related to the Argentina contract - impacts contract deployment and maritime operations.

More from Analyst Ratings

Palantir Gains After Lofty 2026 Guidance; Analysts Split on Outlook Feb 2, 2026 Freedom Capital Markets Starts Coverage of Nebius Group With Buy Rating, $108 Target Feb 2, 2026 Clear Street Starts Coverage on Caribou Biosciences with Buy Rating and $13 Target Feb 2, 2026 Goldman Keeps OLN Neutral at $22 as Olin Signals Rough Q1, Cost Cuts to Cushion Results Feb 2, 2026 Aletheia Capital Starts Coverage on Teradyne With Buy Rating, $400 Target Feb 2, 2026